(14151588), I. E., (3592601), H. E., & (832403), D. A. (2023). Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management.
Chicago Style (17th ed.) Citation(14151588), Islam Eljilany, Hazem Elewa (3592601), and Daoud Al-Badriyeh (832403). Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management. 2023.
MLA (9th ed.) Citation(14151588), Islam Eljilany, et al. Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management. 2023.
Warning: These citations may not always be 100% accurate.